Abstract
There is a lack of guidelines regarding the selection of patients who need intravenous heparin, duration of intravenous heparin, and future use of warfarin in prevention and treatment of warfarin-induced skin necrosis. This case report emphasizes the challenges in dealing with vitamin K antagonists (VKA) therapy.
MeSH terms
-
Aged
-
Anticoagulants / adverse effects*
-
Combined Modality Therapy
-
Drug Administration Schedule
-
Heparin / administration & dosage
-
Humans
-
Male
-
Necrosis / chemically induced
-
Skin / pathology*
-
Systemic Inflammatory Response Syndrome / complications*
-
Thrombophilia / complications
-
Vitamin K Deficiency / chemically induced*
-
Vitamin K Deficiency / complications
-
Warfarin / adverse effects*
Substances
-
Anticoagulants
-
Warfarin
-
Heparin